Your browser doesn't support javascript.
loading
Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
Haldar, Pranabashis; Brightling, Christopher E; Singapuri, Amisha; Hargadon, Beverley; Gupta, Sumit; Monteiro, William; Bradding, Peter; Green, Ruth H; Wardlaw, Andrew J; Ortega, Hector; Pavord, Ian D.
Affiliation
  • Haldar P; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
  • Brightling CE; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
  • Singapuri A; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom.
  • Hargadon B; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom.
  • Gupta S; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
  • Monteiro W; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom.
  • Bradding P; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
  • Green RH; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom.
  • Wardlaw AJ; Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom.
  • Ortega H; Respiratory Therapeutic Area Unit, R&D, GlaxoSmithKline, Research Triangle Park, NC.
  • Pavord ID; Respiratory Medicine Unit, Nuffield Department of Medicine, University of Oxford, Old Road Campus, Headington, Oxford, United Kingdom. Electronic address: ian.pavord@ndm.ox.ac.uk.
J Allergy Clin Immunol ; 133(3): 921-3, 2014 Mar.
Article in En | MEDLINE | ID: mdl-24418480

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Eosinophilia / Asthma / Interleukin-5 / Antibodies, Monoclonal, Humanized Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: J Allergy Clin Immunol Year: 2014 Document type: Article Affiliation country: United kingdom Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pulmonary Eosinophilia / Asthma / Interleukin-5 / Antibodies, Monoclonal, Humanized Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: J Allergy Clin Immunol Year: 2014 Document type: Article Affiliation country: United kingdom Country of publication: United States